HF 358

as introduced - 86th Legislature (2009 - 2010) Posted on 02/09/2010 01:36am

A bill for an act
relating to insurance; limiting excessive co-payments on drugs to treat multiple
sclerosis; proposing coding for new law in Minnesota Statutes, chapter 62Q.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

new text begin [62Q.528] MULTIPLE SCLEROSIS DRUGS; CO-PAYMENTS
LIMITED.
new text end

new text begin (a) For purposes of this section, "multiple sclerosis drug" means a drug that is
approved by the federal Food and Drug Administration for the treatment of multiple
sclerosis.
new text end

new text begin (b) No health plan, as defined in section 62Q.01, subdivision 3, may assess a
co-payment in excess of $50 per 30-day supply of a multiple sclerosis drug.
new text end

new text begin (c) Paragraph (b) does not apply if the multiple sclerosis drug has a less expensive
generic equivalent approved by the federal Food and Drug Administration for treatment
of multiple sclerosis which the patient's treating physician for multiple sclerosis has
determined is equally safe and effective for the patient.
new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective August 1, 2009, and applies to health
plans issued, renewed, or continued as defined in section 60A.02, subdivision 2a, on or
after that date.
new text end